LIDOCAINE 23% / TETRACAINE 7%
LIDOCAINE 23% / TETRACAINE 7%
Approved
Approval ID
8916e10e-a3b9-de1c-e053-2995a90a7e11
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 4, 2020
Manufacturers
FDA
Sincerus Florida, LLC
DUNS: 080105003
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LIDOCAINE 23% / TETRACAINE 7%
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code72934-2140
Product Classification
G
Generic Name
LIDOCAINE 23% / TETRACAINE 7%
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 4, 2020
FDA Product Classification
INGREDIENTS (2)
LIDOCAINEActive
Quantity: 23 g in 100 g
Code: 98PI200987
Classification: ACTIB
TETRACAINEActive
Quantity: 7 g in 100 g
Code: 0619F35CGV
Classification: ACTIB